Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Tax Provisions (2017 - 2025)

Fortress Biotech has reported Tax Provisions over the past 7 years, most recently at -$698000.0 for Q4 2025.

  • Quarterly results put Tax Provisions at -$698000.0 for Q4 2025, down 315.43% from a year ago — trailing twelve months through Dec 2025 was -$279000.0 (down 170.99% YoY), and the annual figure for FY2025 was -$498000.0, down 266.0%.
  • Tax Provisions for Q4 2025 was -$698000.0 at Fortress Biotech, down from $26000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for FBIO hit a ceiling of $473000.0 in Q4 2021 and a floor of -$698000.0 in Q4 2025.
  • Median Tax Provisions over the past 5 years was $127000.0 (2023), compared with a mean of $106000.0.
  • Biggest five-year swings in Tax Provisions: skyrocketed 110.39% in 2024 and later plummeted 315.43% in 2025.
  • Fortress Biotech's Tax Provisions stood at $473000.0 in 2021, then fell by 15.43% to $400000.0 in 2022, then tumbled by 61.5% to $154000.0 in 2023, then skyrocketed by 110.39% to $324000.0 in 2024, then plummeted by 315.43% to -$698000.0 in 2025.
  • The last three reported values for Tax Provisions were -$698000.0 (Q4 2025), $26000.0 (Q3 2025), and $324000.0 (Q4 2024) per Business Quant data.